We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.82%
5 Year Est. Return
+139.61%
10 Year Est. Return
AUM
$2.58B
AUM Growth
+$791M
Cap. Flow
+$834M
Cap. Flow %
32.29%
Top 10 Hldgs %
53.37%
Holding
2,471
New
1,056
Increased
297
Reduced
248
Closed
869

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$51.5M
2
AMZN icon
Amazon
AMZN
+$42.5M
3
MSFT icon
Microsoft
MSFT
+$31.2M
4
UNH icon
UnitedHealth
UNH
+$25.7M
5
ZG icon
Zillow
ZG
+$21.9M

Sector Composition

Rank Sector Weight
1 Communication Services 27.63%
2 Financials 13.6%
3 Technology 7.33%
4 Healthcare 5.05%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLYM
1326
Climb Bio
CLYM
$703M
$43K ﹤0.01%
+10,655
New +$25.6K
CLPR
1327
Clipper Realty
CLPR
$46.5M
$42K ﹤0.01%
+10,938
New +$40.9K
LXRX icon
1328
Lexicon Pharmaceuticals
LXRX
$1.03B
$42K ﹤0.01%
+36,468
New +$50.1K
HBIO icon
1329
Harvard Bioscience
HBIO
$27.5M
$40K ﹤0.01%
+5,951
New +$35.3K
RPTX
1330
DELISTED
Repare Therapeutics
RPTX
$40K ﹤0.01%
+15,488
New +$31.2K
NIXX
1331
Nixxy Inc
NIXX
$18.8M
$40K ﹤0.01%
+41,298
New +$55.3K
CCCC icon
1332
C4 Therapeutics
CCCC
$398M
$39K ﹤0.01%
+20,655
New +$48.9K
CDLX icon
1333
Cardlytics
CDLX
$22.6M
$39K ﹤0.01%
+3,426
New +$52.9K
ELDN icon
1334
Eledon Pharmaceuticals
ELDN
$260M
$39K ﹤0.01%
+25,920
New +$61.6K
ICCM icon
1335
IceCure Medical
ICCM
$9.87M
$39K ﹤0.01%
+2,151
New +$48.3K
DARE icon
1336
Dare Bioscience
DARE
$17.8M
$37K ﹤0.01%
19,200
+1,460
+8% +$2.91K
VIP
1337
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$36.3M
$37K ﹤0.01%
+24,854
New +$43.1K
NOTV
1338
DELISTED
Inotiv
NOTV
$37K ﹤0.01%
66,331
+50,293
+314% +$52.6K
DOUG icon
1339
Douglas Elliman
DOUG
$157M
$36K ﹤0.01%
+15,384
New +$39.6K
INHD icon
1340
Inno Holdings
INHD
$36K ﹤0.01%
+1,579
New +$526K
ACHR.WS icon
1341
Archer Aviation Redeemable Warrants
ACHR.WS
$12.7M
$35K ﹤0.01%
+30,187
New +$68K
BOF icon
1342
BranchOut Food
BOF
$60.5M
$35K ﹤0.01%
+11,112
New +$32K
LITS
1343
Lite Strategy Inc
LITS
$33.1M
$35K ﹤0.01%
26,636
+13,151
+98% +$24.8K
LFWD icon
1344
ReWalk Robotics
LFWD
$20M
$35K ﹤0.01%
5,040
+3,087
+158% +$24K
ALEC icon
1345
Alector
ALEC
$172M
$34K ﹤0.01%
+21,886
New +$38.8K
MRVI icon
1346
Maravai LifeSciences
MRVI
$978M
$34K ﹤0.01%
+10,309
New +$34.7K
SMRT icon
1347
SmartRent
SMRT
$197M
$34K ﹤0.01%
16,811
-31,802
-65% -$52.1K
VGZ icon
1348
Vista Gold
VGZ
$250M
$34K ﹤0.01%
+17,215
New +$33.2K
IRD
1349
Opus Genetics
IRD
$287M
$34K ﹤0.01%
+16,810
New +$34.1K
ETS
1350
Elite Express Holding Inc
ETS
$53.6M
$34K ﹤0.01%
68,386
+12,034
+21% +$7.78K

Similar funds

Virtu Financial's Q4 2025 Portfolio in Review

As of Q4 2025, Virtu Financial held 2,471 positions worth $2.58B, up 44% from $1.79B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Virtu Financial deployed $834M of net new capital in Q4 2025, opening 1,056 new positions and adding to 297 existing holdings. Its largest new stake was SPDR Gold Trust: 1,198,436 shares worth $475M.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $51.5M trimmed.

  • Virtu Financial's largest Q4 2025 buy was SPDR Gold Trust: 1,198,436 shares worth $475M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q4 2025, an estimated $518M increase.
  • Virtu Financial's biggest Q4 2025 reduction was Berkshire Hathaway Class A, cutting an estimated $51.5M.
  • Virtu Financial fully exited Amazon in Q4 2025, selling an estimated $42.5M.
  • Virtu Financial's ten largest holdings make up 53% of its $2.58B portfolio in Q4 2025.
  • Virtu Financial opened 1,056 new positions and closed 869 in Q4 2025.
  • Virtu Financial's portfolio value rose 44% quarter-over-quarter to $2.58B.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.